You are here

GLYTR THERAPEUTICS, INC.

Company Information
Address
5151 CALIFORNIA AVE STE 150
IRVINE, CA 92617-3206
United States


http://www.glytrtherapeutics.com

Information

UEI: ZKQLT6S8LXY9

# of Employees: 1


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Extended half-life GlyTR1 combined with checkpoint blockade for Cancer Immunotherapy

    Amount: $400,000.00

    AbstractTreatment of non-resectable recurrent/metastatic solid cancers is currently palliative only and there is an urgent unmet need for novel mechanisms of action and additional paradigm shifting th ...

    STTRPhase I2023Department of Health and Human Services National Institutes of Health
  2. Cancer Immunotherapy Targeting Tn Antigen

    Amount: $398,178.00

    AbstractCancer immunotherapeutic bi-specific proteins and engineered Chimeric Antigen Receptor T cells (CAR T) have shown remarkable clinical activity, with complete response rates as high as ~90% for ...

    STTRPhase I2021Department of Health and Human Services National Institutes of Health
  3. O-Glycan-dependent Immunotherapy for Cancer

    Amount: $300,614.00

    Abstract For decadesthe treatment of cancer has relied on surgical resectionchemotherapy and or radiotherapyRecentlya number of immune based therapies have provided promising new approaches for cancer ...

    STTRPhase I2018Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government